Literature DB >> 32266448

[Gene-specific treatment of neurological diseases-current state and perspectives].

D Brenner1, A C Ludolph2.   

Abstract

Entities:  

Year:  2020        PMID： 32266448     DOI： 10.1007/s00115-020-00868-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  2 in total

Review 1.  Antisense oligonucleotide therapies: the promise and the challenges from a toxicologic pathologist's perspective.

Authors:  Kendall S Frazier
Journal:  Toxicol Pathol       Date:  2014-11-09       Impact factor: 1.902

Review 2.  Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases.

Authors:  Kathleen M Schoch; Timothy M Miller
Journal:  Neuron       Date:  2017-06-21       Impact factor: 17.173
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.